13F-HR filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 31 holding rows worth $343,725,426.
- Accession
- 0001937964-24-000001
- Filer
- CIK 1937964
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 31 entries on the cover page, a total value of $343,725,426 stated on the cover page (in dollars after the unit check, H1), rows summing to $343,725,426 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NOVO-NORDISK A S ADR | 670100205 | ADR | 721,507 | $74,639,899 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 92,593 | $53,974,312 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 329,200 | $35,889,384 | dollars as filed | |
| CYTOKINETICS INC | 23282W905 | COM NEW | 404,900 | $33,805,101 | dollars as filed | call |
| CYTOKINETICS INC | 23282W955 | PUT | 400,500 | $33,437,745 | dollars as filed | put |
| ELI LILLY & CO | 532457958 | PUT | 40,000 | $23,316,800 | dollars as filed | put |
| AbbVie,Inc. | 00287Y109 | COM | 90,821 | $14,074,530 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 34,238 | $13,025,162 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 190,752 | $12,847,147 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 383,580 | $7,138,424 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 87,848 | $6,991,822 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 45,000 | $5,929,200 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 41,600 | $2,979,392 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 28,885 | $2,785,092 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 32,113 | $2,681,114 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 130,790 | $2,600,105 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 112,340 | $2,575,956 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 38,555 | $2,421,254 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 74,936 | $2,322,267 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 440,000 | $1,962,400 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 100,000 | $1,811,000 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 6,905 | $1,632,342 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 50,000 | $1,155,500 | dollars as filed | |
| WATERS CORP COM | 941848103 | Stock | 2,845 | $936,659 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 21,397 | $901,456 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 19,638 | $488,004 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC | 86366E956 | PUT | 10,000 | $407,600 | dollars as filed | put |
| BIOMEA FUSION INC | 09077A106 | CMN | 25,452 | $369,563 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 10,381 | $290,045 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 95,170 | $194,147 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 10,253 | $142,004 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001937964-24-000001 | this filing | 2024-02-14 | acceptance time not in the bulk data set |